Smoking during pregnancy: subsequent effects on offspring immune competence and disease vulnerability in later life.
About 1 million babies are born each year after prenatal cigarette smoke (CS) exposure from maternal smoking which does not include involuntary maternal exposure to passive smoke. While past emphasis has been on immediately obvious perinatal consequences (e.g., preterm delivery, and low birthweight), smoking during pregnancy has recently emerged as a possible risk factor for later onset disease outcomes in the prenatally exposed offspring. This review brings together those epidemiologic and toxicologic studies demonstrating a link between prenatal CS exposure and subsequent disease vulnerabilities in the progeny. While disorders such as obesity, and type 2 diabetes are included in this category, this paper focuses on two immunologically-related outcomes, cancer and asthma. The review defines the current state of knowledge in this understudied area of children's health, sheds light on the seriousness of such disease vulnerabilities, and reveals gaps that need to be filled to provide a better understanding of the extent and nature of the problem.
Ng
Sheung P
SP
New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY, USA.
Zelikoff
Judith T
JT
D004198:Disease Susceptibility / Q000276:immunology*; D005260:Female; D006801:Humans; D007121:Immunocompetence / Q000187:drug effects* / Q000276:immunology; D007231:Infant, Newborn; D018448:Models, Immunological; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012907:Smoking / Q000009:adverse effects*